SCHEMBL30183282

SCHEMBL30183282

CN(C)C1CCN(C(=O)Cc2cccc(NC(=O)c3n[nH]c4c3C(C)(C)Cc3cnc(N)nc3-4)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 8/20 0.39
AURKA O14965 4/20 0.39
ATR Q13535 3/20 0.39
CCNA2 P20248 3/20 0.37
CCNA1 P78396 3/20 0.37
PDGFRB P09619 1/20 0.36
KDR P35968 1/20 0.36
CSNK2A1 P68400 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
NTRK1 P04629 1/20 0.34
PAICS P22234 1/20 0.34
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
PIP4K2A P48426 1/20 0.33
PIP4K2B P78356 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20649069 1.00 CDK2 (0.39) CDK2AURKAATRCCNA2CCNA1
SCHEMBL20649066 0.96 ATR (0.42) CDK2AURKAATRCCNA2CCNA1
SCHEMBL20649064 0.96 ATR (0.42) CDK2AURKAATRCCNA2CCNA1
SCHEMBL30183173 0.96 ATR (0.42) CDK2AURKAATRCCNA2CCNA1
SCHEMBL20649118 0.92 CDK2 (0.38) CDK2AURKACCNA2CCNA1PDGFRB
Hydrochloric Acid SCHEMBL30183514 0.92 CDK2 (0.38) CDK2AURKACCNA2CCNA1PDGFRB
Hydrochloric Acid SCHEMBL21875630 0.92 CDK2 (0.38) CDK2AURKACCNA2CCNA1PDGFRB
SCHEMBL21875705 0.91 CDK2 (0.36) CDK2AURKAATRCCNA2CCNA1
SCHEMBL20649161 0.90 CDK2 (0.45) CDK2AURKACCNA2CCNA1CDK5
SCHEMBL30183523 0.90 CDK2 (0.45) CDK2AURKACCNA2CCNA1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN claimed
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed